https://www.selleckchem.com/pr....oducts/golvatinib-e7
Previous studies have suggested improved efficiency and patient outcomes with 125I seed compared with hookwire localization (HWL) in breast-conserving surgery, but high-level evidence of superior surgical outcomes is lacking. The aim of this multicentre pragmatic RCT was to compare re-excision and positive margin rates after localization using 125I seed or hookwire in women with non-palpable breast cancer. Between September 2013 and March 2018, women with non-palpable breast cancer eligible for breast-conserving surgery were as
إعجاب
علق
شارك
